Future’s Fading Bloom — A Haiku on Mifepristone Access

The Story Behind the Haiku

A significant legal ruling by a US appeals court has placed new restrictions on access to mifepristone, a widely used abortion medication. This decision effectively blocks the FDA’s long-standing approval for mailing the drug and limits its availability to in-person dispensing by doctors. While further appeals may alter the final outcome, this ruling profoundly impacts reproductive healthcare across the United States. Advocates for abortion rights decry the decision as a severe blow to bodily autonomy and public health, while opponents hail it as a victory. The case represents a critical shift in how medication abortion, accounting for over half of all abortions nationally, will be managed, creating uncertainty for millions.